Journal of the Royal Society ofMedicine Volume 71 July 1978 suitable for human use. Apart from the conventional problem of excluding pathogens, there will be a particular risk of contamination with blood group substance if the present techniques are used for cultivation of malaria parasites. In this connection, vaccines prepared from extracellular merozoites are likely to prove more acceptable than those isolated from erythrocytes containing normal or attenuated parasites. A further problem concerns the requirement for the clinically unacceptable Freund's complete adjuvant in vaccines such as those which have proved effective against simian malaria (Table I ). The relevance of such experimental models to human populations is difficult to assess. Susceptibility to malaria is influenced by many factors including bloodgroup specificity, haemoglobin constitution and genetically-determined differences in patterns of immune responsiveness. There is convincing evidence in human populations that malaria selects for genes controlling not only haemoglobin synthesis and blood-group specificity, but also HLA specificity. The immune response of a given population to malaria vaccination is likely to bestrongly influenced by such antecedent selection. The adjuvant requirements in exposed subjects may, therefore, be less stringent than in experimental malaria, which relates almost exclusively to infections in unnatural hosts. The ultimate choice of adjuvant will be restricted to those acceptable for human use and will be guided by knowledge of the mechanisms of malarial immunity and the action of available adjuvants; understanding of both of these topics is at present incomplete.
S The report underlines the important educational contribution of the pharmaceutical industry and recommends whole-heartedly that the present limitations which restrict patronage of the Postgraduate Medical Centres by the pharmaceutical industry should be lifted. To this end it is proposed that the Forum should set up an Education Advisory Board, which should do something to allay any anxieties that postgraduate deans and clinical tutors might have in such a changed climate. It is also recommended that each pharmaceutical firm which is actively engaged in postgraduate medical education should nominate an individual whom clinical tutors and others can contact on educational matters. Whilst such recommendations may not be universally popular they will probably seem satisfactory to the majority of the profession.
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